New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

A new FDA-approved drug may let some rectal cancer patients avoid chemo, radiation, and surgery. The immunotherapy Jemperli offers a less invasive treatment option for early-stage cases.